Clinical Development
At Reistone, we devised our clinical development strategy around three key pillars: Science, People and Process. 

Pursue the best science:
We strive to develop a robust portfolio of clinical ready and clinical-stage breakthrough medicines with novel modes of action building on rigorous scientific foundation. 

Empowered passionate people:  
Reistone has built a strong clinical development team with highly capable and rich clinical development experience in both global and China clinical trials.

Streamline processes:
Reistone has built solid internal processes ensuring seamless and collaborative working across multi-functions. End to end processes are ready to ensure the right development strategy, high quality study design, vendor selection, management, efficient study monitoring and quality assurance, etc.